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Dopamine-fS-hydroxylase (DBH), the enzyme responsible for the conver- 
sion of dopamine to norepinephrine, was measured in the plasma of two 
lines of mice selectively bred for differential sensitivity to hypnotic doses 
of ethanol. Plasma levels of DBH were measured by radioenzymatic assay 
in long sleep (LS) and short sleep (SS) male and female mice which had 
no prior exposure to ethanol. LS mice had ,significantly higher plasma 
DBH activity than did SS mice, although no significant sex difference 
was found. Fusaric acid, an inhibitor of both central and peripheral DBH, 
attenuated sleep time induced by either 3 or 4 g/kg ethanol in mice of a 
heterogeneous genetic stock. The results of these experiments may further 
implicate noradrenergic systems in mediating some of the depressed ef- 
fects of ethanol. 
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INTRODUCTION 
Using a selective breeding procedure, McClearn and Kakihana (1973) 
have produced two lines of mice which differ markedly in response to 
hypnotic doses of ethyl alcohol. The selective breeding methodologies 
for these two lines, designated long sleep (LS) and short sleep (SS), have 
been presented elsewhere (McClearn and Kakihana, 1973). Several stud- 
ies have attempted to elucidate biochemical and neurochemical differ- 
ences between these two lines which might underlie the differential re- 
sponse to ethanol treatment (e.g., Collins et al., 1976; Collins and 
Deitrich, 1973; Heston et al., 1974). 
Given that previous research had demonstrated a significant negative 
correlation betweeen sleep time and alcohol dehydrogenase activity fol- 
lowing alcohol challenge among mice of the heterogeneous founding pop- 
ulation (Belknap et al., 1972), the initial studies focused on factors which 
would affect alcohol metabolism. Heston et al. (1974) found no differences 
in the activity of either liver alcohol dehydrogenase or liver aldehyde 
dehydrogenase. In addition, blood alcohol levels appear to be similar in 
the LS and SS lines, making it unlikely that differences in absorption and 
distribution of alcohol account for the large differences in sleep time. 
In another line of investigation, brain neurotransmitter systems were 
examined in the two lines. Whole-brain levels of dopamine and norepi- 
nephrine appear to be lower in LS mice than SS mice (Collins and Dei- 
trich, 1973; Collins et aL, 1976). In addition, LS mice have been shown 
to have a lower cortical density of 13-adrenergic receptors than SS mice 
(Dibner et al., 1980). 
Although the physiological consequences of bidirectional selective 
breeding for the phenotype of ethanol-induced narcosis among LS and 
SS mice are not fully understood, the results from nongenetic studies of 
neurotransmitter systems suggest a possible involvement of the norad- 
renergic system in this hypnotic response to ethanol. For example, Hay- 
ashida and Smith (1971) reported that sotalol, a [3-adrenergic antagonist, 
significantly attenuated the duration of sleep time induced by 4 g/kg 
ethanol in Swiss-Webster mice. Additionally, these researchers (Smith 
et al., 1970) have reported that low doses of propranolol, another 13- 
adrenergic blocking agent and norepinephrine releaser, reduced ethanol 
sleep time in mice of the same line. Further support for the hypothesis 
of noradrenergic mediation of some of the depressant effects of ethanol 
in mice can be gleaned from a study by Matchett and Erickson (1977), 
who found that propranolol attenuated the initial hypoactivity produced 
by 2 g/kg ethanol. Interestingly, propranolol was without effect on the 
later hyperactivity produced by this subhypnotic dose of ethanol. How- 
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ever, the cx-adrenergic blocking agent, phentolamine, antagonized the hy- 
peractivity phase but was without effect on the earlier phase of hypoac- 
tivity. These investigators concluded that the depressant effect of alcohol 
on locomotor activity may be mediated by central [3-adrenergic receptors, 
while the stimulant effect of ethanol may be mediated by central a-ad- 
renergic receptors. In light of this hypothesis, it is interesting to note that, 
while LS mice are clearly more sensitive to the effects of hypnotic doses 
of ethanol, SS mice have been reported to show a greater increase in 
locomotor activity following lower doses of ethanol (Sanders, 1976). 
If noradrenergic neurotransmitter systems are involved in the de- 
pressant effects of ethanol in general, or in the phenotypic difference 
between LS and SS mice in ethanol-induced narcosis in particular, then 
alterations in the enzymes responsible for norepinephrine metabolism 
might be evident as correlated responses to selection. However, differ- 
ences between LS and SS mice were not found by Collins.et al. (1976) 
in certain enzymes of catecholamine synthesis (tyrosine hydroxylase, 
dopa decarboxylase) or degradation (monoamine oxidase). These re- 
searchers were unable to measure dopamine-f3-hydroxylase (DBH) from 
brain tissue, presumably because of high levels of endogenous inhibitors 
(Nagatsu et al., 1967). DBH [3,4-dihydroxyphenylethylamine ascorbate: 
O-oxidoreductase (hydroxylating; EC 1.14.2.1)] is the enzyme re sponsible 
for the conversion of dopamine to norepinephrine. This enzyme is lo- 
calized in noradrenergic storage vesicles, where it exists in both soluble 
and membrane-bound forms (Viveros et al., 1968; Smith and Winkler, 
1972). During exocytosis, a portion of the soluble fraction of DBH may 
be released into the extraceUular fluid. Studies involving in vitro prepa- 
rations of noradrenergic tissue show that norepinephrine and DBH are 
released proportionally in response to depolarizing agents (Geffen et al., 
1969; Viveros et al., 1968; Weinshilboum et al., 1971). 
Numerous DBH inhibitors have been shown to reduce norepineph- 
rine levels significantly, both centrally and peripherally, thereby altering 
noradrenergic activity. Hidaka et al. (1974) have shown that DBH inhib- 
itors which do not cross the blood-brain barrier, such as 5-dimethyldi- 
thiocarbamylpicolinic acid (YP-279), have no effect on ethanol-induced 
sleeping time, while inhibitors such as 5-butylpicolinic acid (fusaric acid), 
which does pass the blood-brain barrier, significantly prolongs ethanol 
sleep time in mice. 
Two experiments were conducted to elucidate further the possible 
role of noradrenergic systems in mediating the loss of righting reflex 
induced by hypnotic doses of ethanol. In the first experiment, plasma 
DBH activity was measured in LS and SS mice in the absence of alcohol. 
In the second experiment, the effect of fusaric acid, a DBH inhibitor, on 
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ethanol-induced narcosis was examined in mice of heterogeneous genetic 
origin. 
EXPERIMENT 1 
In the first study, plasma DBH activity was examined in LS and SS 
mice as a further investigation of potential differences in the noradrenergic 
nervous system between LS and SS mice. Brain DBH activity was not 
measured because, in previous attempts, we were unable to measure 
mouse brain DBH activity using a double radioenzymatic assay. This 
finding is in agreement with a previous report by Collins et  al. (1976), 
who were also not able to measure brain tissue DBH levels. We found 
0% recovery of exogenously added purified DBH in all brain homogenate 
samples, which would support the hypothesis that high levels of endo- 
genous inhibitors are responsible for the apparent lack of DBH activity 
in mouse brain. 
Materials and Methods 
The subjects were descendents of the mice selectively bred by 
McClearn and Kakihana (1973) for differential sensitivity to hypnotic 
doses of ethanol. Mating pairs were obtained from the Institute for Be- 
havioral Genetics (University of Colorado, Boulder) at generation 18 and 
have been maintained at the present laboratory with relaxed selection 
within each line. A minimum of 15 mating pairs has been maintained for 
each line, with the restriction that the progeny of each pair did not share 
common grandparents. In the present study, a total of 13 SS (females, 
N = 6; males, N = 7) and 14 LS (females, N = 6; males, N = 8) mice 
was tested. The animals were weaned at 21 days and housed as like-sexed 
littermates until the beginning of the experiment. During rearing, the 
animals were exposed to a 12-h light/12-h dark photoperiod, with the light 
period beginning at 0730 each morning, with food and water being avail- 
able ad libitum. The ages of the mice at the time of testing were approx- 
imately equal within each line (mean -+ SE--114.9 -_+ 8.5 and 114.2 ___ 
8.3 days for LS and SS mice, respectively). 
Mice were sacrificed by decapitation and blood was collected in a 
30-ml beaker containing 100 IU sodium heparin. Samples were kept on 
ice until centrifuged at 1500 g for 10 min at 4~ Plasma samples were 
then stored at -40~ until assayed. 
DBH was assayed by a modification of a double radioenzymatic 
method (Molinoff et  al., 1971). Each sample was analyzed in duplicate, 
using a 15-1xl aliquot of plasma added to a tube containing the following: 
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sodium acetate buffer (2.5 x 10 -5 mol), ascorbic acid (3 x 10 - 6  tool), 
pargyline hydrochloride (5 x 10 - 7  mol), N-ethylmaleimide (2.5 x 10 - 6  
tool), sodium fumarate (5 • 10 - 6  tool), catalase (2250 U; Calbiochem, 
La Jolla, Calif.), tyramine hydrochloride (3 >< 10 - 6  mol), and H20 to 
bring the final volume to 500 Ixl. Tubes were incubated for 60 rain at 37~ 
Following this incubation, 205 txl of a mixture containing potassium phos- 
phate buffer (1.5 x 10 - 4  tool), cysteine (5 x 10 - 6  mol), 14C-S-adeno- 
sylmethionine (sp act, 50-60 Ci/mmol; 3.4 x 10 - 6  mol; ICN Radiochem- 
icals, Irvine, Calif.), and 5 ~1 of a phenylethanolamine-N-methyltransferase 
(PNMT) solution (purified from bovine adrenyl glands) was added to all 
tubes before a second incubation at 37~ for 40 rain. All reagents were 
purchased from the Sigma Chemical Co., St. Louis, Mo., unless otherwise 
noted. 
Octopamine formed in the first reaction was converted to  14C-sy- 
nephrine in the second (PNMT) step. The second reaction was terminated 
by adding 0.5 ml of 0.5 M sodium borate buffer, pH 10, to all tubes and 
removing them from the water bath. 14C-Synephrine was extracted away 
from radioactive precursors using a toluene isoamyl alcohol solvent sys- 
tem. Final activity of DBH was quantified using octopamine standards. 
Liquid scintillation spectrometry utilized a Packard Tri-Carb counter 
(Packard Instruments, Downers Grove, I11.). 
Recovery of DBH was measured by adding known amounts of pur- 
ified DBH (Sigma) to plasma samples and testing assay recovery of ex- 
ogenously added enzyme. 
Results and Discussion 
Mouse plasma samples were found to have measurable levels of DBH 
activity which were significantly different between LS and SS mice. The 
enzyme activity scores were subjected to a 2 (genotype) x 2 (sex) un- 
weighted-means analysis of variance. As seen in Fig. 1, the main effect 
of genotype was significant, [F(1,23) = 32.1, P - 0.001], with LS mice 
displaying greater enzyme activity than SS mice regardless of sex. A main 
effect of sex was not detected [F(1,23) = 1.98, P -> 0.05], nor was there 
a significant genotype x sex interaction, F -<- 1. 
Assay recovery of DBH from plasma was estimated in each line and 
sex. Recovery was approximately 90%, with no apparent differences be- 
tween genotype or sexes. 
Several individual factors may affect plasma DBH activity and must 
be considered in the interpretation of the differences presently reported 
between LS and SS mice. No difference was observed in plasma levels 
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Fig. 1. Plasma dopamine-#-hydroxylase (DBH) activity, expressed as nanomoles of prod- 
uct per milliliter of plasma per hour, in long sleep (LS) and short sleep (SS) mice of each 
sex. Values shown are the means (+  SE) for six to eight mice. 
of endogenous inhibitors, as recovery of exogenous DBH was found to 
be the same in both lines. This finding rules out artifactual differences in 
DBH activity caused by differing inhibitor levels. However, factors other 
than sympathetic activity, especially metabolic clearance, may exert an 
overriding influence on the level of serum enzyme activity. 
The previously reported studies showing higher levels of whole-brain 
norepinephrine in SS mice (Collins and Deitrich, 1973; Collins et al., 
1976) and higher levels of cortical ~-adrenergic receptor density in SS 
animals (Dibner et al., 1980) suggest that increased central noradrenergic 
activity is somehow responsible for the early recovery from hypnotic 
doses, and perhaps the greater stimulatory effects of lower doses, of 
ethanol in SS mice. Our present finding of lowered plasma DBH activity 
in SS mice would be consistent with these previous findings if, in fact, 
lowered plasma DBH activity in LS mice is a reflection of increased 
central noradrenergic inhibitory control of sympathetic outflow. 
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The hypothesis that differences in central noradrenergic systems are 
responsible for the seemingly paradoxical finding of greater peripheral 
DBH activity in LS mice can be tested by the use of relatively specific 
DBH inhibitors. Since the inhibition of DBH by fusaric acid has been 
shown to reduce central norephihephrine levels, (Hidaka et aI., 1974), the 
activity of both o~- and [3-noradrenergic systems should be reduced by this 
agent. If a-noradrenergic systems mediate the activating effects of 
ethanol, as suggested by Matchett and Erickson (1977), then DBH inhi- 
bition might be predicted to prolong ethanol-induced sleep time. In the 
second experiment, the effects of fusaric acid on ethanol-induced sleep 
time was assessed in mice of heterogeneous genetic origin. 
EXPERIMENT 2 
The results of the first experiment suggest that LS mice, which shows 
greater sensitivity to the loss of righting reflex induced by ethanol, also 
show higher activity levels of DBH. These findings suggest a relationship 
between the noradrenergic nervous system and the ethanol-induced sleep 
time. Other evidence for noradrenergic involvement comes from the re- 
ports that ~-adrenergic antagonists, such as propranolol and sotalol, at- 
tenuate ethanol-induced sleep time in mice (Hayashida and Smith, 1971; 
Smith et al., 1970) and that propranolol antagonizes the depressant effect 
of ethanol on locomotor activity (Matchett and Erickson, 1977). There 
is one report in the literature on the effects of a DBH inhibitor on ethanol- 
induced sleep. Hidaka et al. (1974) have reported that pretreatment with 
fusaric acid significantly prolonged ethanol-induced sleep time in mice 
of the DBA inbred strain. Since strain differences in response to a variety 
of pharmacologic agents have now been well documented, this finding 
may be specific to DBA mice. Thus, the second experiment was designed 
to evaluate the effects of DBH inhibition on ethanol-induced narcosis in 
mice of a heterogeneous genetic stock. It should be noted that the LS 
and SS lines were derived from a similar, but not identical, founding 
population. 
Materials and Methods 
A total of 44 mice of the Binghamton heterogeneous (HET) stock, 
82-105 days of age, was used as subjects. These mice were derived from 
a systematic cross of eight inbred strains (see Fuller, 1979) and are main- 
tained through breeding pairs which do not share common grandparents. 
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The subjects represented the progeny of 16 different mating pairs. Fol- 
lowing weaning at postnatal day 21, they were housed as like-sexed lit- 
termates in a temperature (22 _+ I~ - and photoperiod (12:12-h light:dark 
cycle; lights on at 0800 h)- controlled vivarium. Each subject was indi- 
vidually housed on the day prior to its first use in the experiment. Food 
and water were available continuously in the home cage throughout rear- 
ing and the experiment. 
On the first morning of the experiment, all subjects were weighed 
and randomly assigned to be injected ip (0.02 mug body wt) with either 
3 (N = 24) or 4 (N = 20) g/kg ethanol (from 15 or 20%, w/v, respectively). 
When each mouse lost the ability to maintain an upright position, it was 
placed on its side in a stainless-steel V-shaped trough, and the time was 
recorded. If the mouse turned to the prone position, it was placed on its 
back. An animal was judged to have regained the righting reflex if it could 
return to an upright position twice within 30 s. The duration of the loss 
of righting reflex was thus calculated as the difference in time between 
losing and regaining the ability to maintain an upright position. 
Following this initial evaluation of ethanol sensitivity, all subjects 
were returned to their home cages in the vivarium at 6 days. For each 
dose of ethanol, two groups of equal numbers of animals were formed on 
the basis of prior sensitivity to ethanol-induced narcosis (see Table I). 
One week after the initial exposure to ethanol, mice were weighed and 
injected with either 25 mg/kg of fusaric acid (Sigma) or an equal volume 
of physiological saline, the vehicle for fusaric acid. Thirty minutes after 
this pretreatment, each subject received an injection of ethanol equal to 
the dose administered to it on the first day of the experiment. The duration 
of the loss of righting reflex was determined as above. 
Results and Discussion 
The duration of the loss of righting reflex, or the sleep time, served 
as the dependent measure of alcohol responsiveness. Sleep times were 
subjected to a 2 (treatments) x 2 (doses of alcohol) x 2 (trials) un- 
weighted-means repeated-measure analysis of variance. The results of 
the experiment are summarized in Table I. 
Analysis of the variance in sleep times revealed a main effect of dose 
[F(1,40) = 124.01, P - 0.01]. As seen in Table I, the sleep time was greater 
following the higher dose of ethanol, regardless of treatment with fusaric 
acid or saline. Similarly, there was a main effect of treatment [F(1,40) 
= 4.96, P -< 0.05]. Since the two treatment groups were matched prior 
to treatment, this difference reflects the lower sleep time of animals re- 
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Table I. The Effects of Fusaric Acid or Saline on Ethanol-Induced 
Sleep Time in HET Mice 
Sleep time (rain) 
Saline Fusaric acid 
Dose of ethanol 
(g/kg) Pre" Post Pre" Post 
3 
35.12 34.65 32.37 18.54 
SE 5.24 2.94 4.81 2.43 
4 
95.47 77.79 94.82 56.48 
SE 7.96 5.79 9.22 3.82 
Ethanol-induced sleep time 1 week prior to treatment with saline or 
fusaric acid (see text). 
ceiving fusaric acid on the second trial. A main effect of trials [F(1,40) 
= 33.71, P - 0.01], is also due mainly to the lower sleep times of fusaric 
acid-treated animals on the second test. However,  control mice receiving 
4 g/kg of ethanol and given saline prior to the second trial also exhibited 
lower sleep times on the latter trial, contributing to a significant dose 
x trial interaction [F(1,40) = 11.88, P -< 0.01]. The reason for this 
decrease is not apparent, but it was not as large as the decrease observed 
in mice receiving this dose of ethanol fallowing fusaric acid pretreatment 
(see Table I). The treatement x trial interaction was also significant 
IF(l,40) = 7.89, P -< 0.01]. Given the matching procedure based on the 
results of the first trial, this finding is again indicative that fusaric acid 
attenuated the sleep time induced by both doses of ethanol. Finally neither 
the treatment x dose nor the treatment x dose x trials interaction 
approached statistical significance (F < 1 for each case). 
These results are not in agreement with the previous report by Hidaka 
et  at. (1974) that fusaric acid lengthened ethanol-induced sleep time in 
DBA mice. It may be that procedural differences account for these dis- 
crepancies between the two studies. Hidaka et  al. (1974) used DBA mice, 
an inbred strain, while we used mice of heterogeneous genetic origin. 
Perhaps DBA mice show a unique response to this combination of drug 
treatments. The DBA genotype is represented[ in the inbred strains from 
which our mice were derived. In fact, of the 22 mice tested in the present 
study showed a slight increase in ethanol-induced sleep time in the ab- 
sence of pretreatment. However,  the most extreme of these three mice 
showed only a 10-rain increase, while the mean decrease in all mice 
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(including these three mice) receiving this dose of ethanol following fu- 
saric acid was about 14 min. 
A second procedural difference between the two studies is related 
to drug dosage and vehicle. While in both studies, 25 mg/kg fusaric acid 
was injected 30 min prior to ethanol administration, the doses of ethanol 
were different. Hidaka et  al. (1974) gave subjects 4.8 g/kg ethanol. Since 
we were interested in the possible role of DBH as a response to selection, 
we injected doses of ethanol that are closer to those employed in the 
selection procedure. It is possible that the fusaric acid-ethanol combi- 
nation has a biphasic dose-response curve. Additionally, the vehicle for 
fusaric acid in the previous study was carboxymethylcellulose (CMC), 
while we dissolved fusaric acid in physiologic saline. Hidaka et al. (1974) 
reported that the mean sleep time of DBA mice pretreated with CMC 
alone, followed by 4.8 g/kg ethanol, was approximately 82 rain. Belknap 
et  al. (1972) have previously reported that DBA mice slept for an average 
of 91 min following 3.55 g/kg ethanol, and Damjanovich and Maclnnes 
(1973) similarly reported a sleep time of about 130 min for these mice 
following 4.1 g/kg ethanol. It is possible that CMC alone decreases sleep 
time but is antagonistic in its interaction with fusaric acid. 
GENERAL DISCUSSION 
The two experiments reported in this paper add further evidence to 
the role of the noradrenergic nervous system in the mediation of ethanol- 
induced loss of the righting reflex in mice. However, the exact nature of 
this involvement remains to be elucidated. We have mentioned a number 
of previous studies which have similarly demonstrated either differences 
in the noradrenergic nervous system between LS and SS mice or the 
ability to alter sleep time by manipulating the noradrenergic nervous 
system in various ways in other populations of mice. 
These previous studies, as well as the results of the first experiment 
reported herein, led to the hypothesis that central noradrenergic systems 
might be inhibitory on peripheral sympathetic activation. Specifically, 
the greater plasma DBH activity of LS mice observed in Experiment i 
might reflect a lower central noradrenergic activity in mice of this line. 
A similar mechanism has been proposed to explain the finding that the 
central administration of norepinephrine or propranolol produces reduc- 
tions in blood pressure in rats (Tackett et  al., 1981). This hypothesis 
would predict that DBH inhibition should potentiate ethanol-induced 
sleep time. However, the results of our second experiment are not con- 
sistent with this prediction; pretreatment with fusaric acid attenuated 
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sleep time in mice of heterogeneous genetic stock following 3- or 4-g/kg 
ethanol doses. 
The collective results of the present experiments do not support the 
hypothesis that the great peripheral DBH activity in LS mice contributes 
to the greater sensitivity to the hypnotic effects of ethanol via the specific 
mechanism of deficient central noradrenergic inhibitory control of pe- 
ripheral sympathetic activity. However, it should be noted that the results 
of the two present experiments are internally consistent. That is, if the 
increased basal plasma DBH activity of LS mice is correlated with the 
longer sleep time following hypnotic doses of ethanol observed in these 
mice, then inhibition of DBH should attenuate ethanol-induced sleep time 
in mice of a heterogeneous genetic stock. This prediction was realized, 
as indicated by the results of the second experiment. 
Although many DBH inhibitors also inhibit other sulfhydryl-contain- 
ing enzymes, fusaric acid has been shown to have no effect on other 
enzymes of monoamine metabolism, including aldehyde deh'ydrogenase, 
at concentrations of up to 10 -4 M (Nagatsu et al., 1970). Thus, it is 
unlikely that the effects of fusaric acid observed in our study are due to 
indirect effects on ethanol metabolism. Furthermore, inhibition of ALDH 
should prolong, not attenuate, ethanol-induced sleep time. Nonetheless, 
further experiments using specific a- and 13-noradrenergic agonists and 
antagonists should prove useful in clarifying the role of noradrenergic 
systems as possible contributors to the observed phenotypic differences 
between LS and SS mice in the selection criterion of ethanol-induced 
sleep time. These experiments are currently being conducted in our 
laboratory. 
It is also possible, of course, that any observed phenotype correlation 
between DBH activity and the previous selection index of ethanol-induced 
sleep time is fortuitous and the result of either a founder effect in estab- 
lishing our colony or a stochastic association of separate genetic systems. 
It would be interesting to note whether the presently observed differences 
in plasma DBH activity are also found among the LS and SS mice main- 
tained at the University of Colorado. 
The use of selective breeding techniques in the area of pharmaCo- 
genetics, as exemplified by the Colorado sleep lines, is valuable in at least 
two respects (Crabbe and Belknap, 1980). First, the successful response 
to selection demonstrates a heritable component to the trait under in- 
vestigation. Second, the products of such bre, edng studies are a valuable 
source of hypotheses of the relationship between the selected phenotype 
and other traits of interest. The present exper~[ments failed to confirm one 
such hypothesis but generated further hypotheses regarding the role of 
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n o r a d r e n e r g i c  n e u r o t r a n s m i t t e r s  s y s t e m s  in the  d i f fe ren t i a l  r e s p o n s e  to 
e t h a n o l  b y  L S  a n d  SS mice .  I t  is h o p e d  tha t  t h e s e  r e su l t s  might  be  in- 
t e g r a t e d  wi th  o t h e r  r e s e a r c h  to  c o n t r i b u t e  to  o u r  ove ra l l  k n o w l e d g e  o f  
t he  n e u r o c h e m i c a l  m e c h a n i s m s  o f  the  d e p r e s s a n t  e f fec t s  o f  e thano l .  
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